Location · Indiana
Clinical trials recruiting in Indiana
433 recruiting studies have at least one site in Indiana; 119 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Indiana.
433 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing
Solventum US LLC
- Location
- Indianapolis, IN + 2 other US sites
- Eligibility basics
- Ages 22+
- RecruitingHealthy volunteers
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Adela, Inc
- Location
- New Albany, IN + 15 other US sites
- Eligibility basics
- Ages 40+
- RecruitingHealthy volunteers
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Corvivo Cardiovascular, Inc.
- Location
- Indianapolis, IN + 3 other US sites
- Eligibility basics
- Ages 1–85
- RecruitingHealthy volunteers
4-day Plaque Accumulation Model Evaluating Compound Containing Gum
Lactea Therapeutics, LLC
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
AvertD Post-Approval Study
Prescient Medicine Holdings, Inc.
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Scalable Intervention for Stress Management
Livotion, LLC
- Location
- West Lafayette, IN
- Eligibility basics
- Ages 18–30
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Indianapolis, IN + 64 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Indianapolis, IN + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Hoffmann-La Roche
- Location
- Mishawaka, IN + 10 other US sites
- Eligibility basics
- Ages 1 mo–11
- RecruitingPhase 3
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
PTC Therapeutics
- Location
- Indianapolis, IN
- Eligibility basics
- Up to age 9
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Hammond, IN + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Hammond, IN + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Merck Sharp & Dohme LLC
- Location
- Indianapolis, IN + 70 other US sites
- Eligibility basics
- Ages 16–80
- Recruiting
Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
VisCardia Inc.
- Location
- Indianapolis, IN + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
LEO Pharma
- Location
- Indianapolis, IN + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Pfizer
- Location
- Fort Wayne, IN + 27 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular…
AbbVie
- Location
- Carmel, IN + 54 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sanofi
- Location
- New Albany, IN + 118 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- Hammond, IN + 70 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Renibus Therapeutics, Inc.
- Location
- Indianapolis, IN + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Novartis Pharmaceuticals
- Location
- Indianapolis, IN + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
Ipsen
- Location
- Indianapolis, IN + 20 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Oruka Therapeutics, Inc.
- Location
- Plainfield, IN + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of MZE782 in Adults With PKU
Maze Therapeutics
- Location
- Indianapolis, IN + 6 other US sites
- Eligibility basics
- Ages 18–75